Baofa Cancer Hospital Network

Baofa Cancer Hospital Network is a specialized healthcare provider and biotechnology entity focused on advanced cancer treatments. Founded by Dr. Sun Baofa, the network operates several hospitals in China and a research institute in the United States. The core of their practice is the proprietary Ultra-fractionated Intratumoral Injection (UFII) and Hapten-enhanced Intratumoral Immunotherapy (HEII). These methods involve injecting a cocktail of chemotherapy drugs and haptens directly into tumors to induce a systemic immune response. This approach aims to minimize systemic toxicity while maximizing local efficacy across various solid tumor types. The network provides integrated care combining traditional oncology with their specialized immunotherapy protocols. Their facilities serve a global patient base seeking alternative or integrative options for advanced malignancies.